SARS-CoV-2 induces neutrophil degranulation and differentiation into myeloid-derived suppressor cells associated with severe COVID-19
Science Translational Medicine · 21.05.2025 · 17 (799)
DOI: 10.1126/scitranslmed.adn7527 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Translational Medicine, erschienen am 21.05.2025. Verfasst von Leon L Hsieh und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Neutrophils, Cell Degranulation. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 80 Literaturangaben. Gefördert von: NIGMS NIH HHS, NIAID NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Severe COVID-19 presents with a distinct immunological profile, characterized by elevated neutrophil and reduced lymphocyte counts, seen commonly in fungal and bacterial infections. This study demonstrates that patients hospitalized with COVID-19 show evidence of neutrophil degranulation and have increased expression of neutrophil surface lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1), a marker of polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs). Both early LOX-1 and programmed death-ligand 1 (PD-L1) expression on neutrophils were associated with development of severe disease. To determine whether tissue damage or inflammation is required to induce PMN-MDSCs or whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) directly activates neutrophils to become PMN-MDSCs, we incubated healthy human neutrophils with SARS-CoV-2. SARS-CoV-2 rapidly induced LOX-1 surface expression in healthy neutrophils independent of productive infection. LOX-1 induction was dependent on granule exocytosis and promoted up-regulation of reactive oxygen species, CD63, and PD-L1, enabling LOX-1 + neutrophils to suppress autologous T cell proliferation in vitro. These results support a role for PMN-MDSCs in mediating severe COVID-19, and inhibition of PD-L1 represents a potential therapeutic strategy for enhancing the immune response in acute SARS-CoV-2 infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
- W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD 21287, USA.
- Department of Biostatistics, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD 21287, USA.
- Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
- Center for Computational Biology, Johns Hopkins University, Baltimore, MD 21287, USA.
- Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
ORCID-Profile: Leon L Hsieh, Elizabeth A Thompson, Nirvani P Jairam, Katerina Roznik, Weiqiang Zhou, Naina Gour, Kuan-Hao Chao, Aaron M Milstone, Franco D'Alessio, Petros C Karakousis, Alvaro Ordoñez, Eileen P Scully, Andrew Pekosz, Andrew H Karaba, Andrea L Cox
Förderung
- NIGMS NIH HHS
- NIAID NIH HHS
- NCI NIH HHS
Zitieren
APA
Hsieh, L. L., Thompson, E. A., Jairam, N. P., Roznik, K., Figueroa, A., Aytenfisu, T., Zhou, W., Gour, N., Chao, K. H., Milstone, A. M., Egbert, E., D'Alessio, F., Karakousis, P. C., Ordoñez, A., Scully, E. P., Pekosz, A., Karaba, A. H., & Cox, A. L. (2025). SARS-CoV-2 induces neutrophil degranulation and differentiation into myeloid-derived suppressor cells associated with severe COVID-19. Science Translational Medicine, 17(799). https://doi.org/10.1126/scitranslmed.adn7527
Vancouver
Hsieh LL, Thompson EA, Jairam NP, Roznik K, Figueroa A, Aytenfisu T, et al. SARS-CoV-2 induces neutrophil degranulation and differentiation into myeloid-derived suppressor cells associated with severe COVID-19. Science Translational Medicine. 2025;17(799). doi:10.1126/scitranslmed.adn7527
BibTeX
@article{Hsieh2025,
author = {Hsieh, Leon L and Thompson, Elizabeth A and Jairam, Nirvani P and Roznik, Katerina and Figueroa, Alexis and Aytenfisu, Tihitina and Zhou, Weiqiang and Gour, Naina and Chao, Kuan-Hao and Milstone, Aaron M and Egbert, Emily and D'Alessio, Franco and Karakousis, Petros C and Ordoñez, Alvaro and Scully, Eileen P and Pekosz, Andrew and Karaba, Andrew H and Cox, Andrea L},
title = {SARS-CoV-2 induces neutrophil degranulation and differentiation into myeloid-derived suppressor cells associated with severe COVID-19},
journal = {Science Translational Medicine},
year = {2025},
volume = {17},
number = {799},
doi = {10.1126/scitranslmed.adn7527}
}
EUVIMED